Mutual of America Capital Management’s Collegium Pharmaceutical COLL Stock Holding History

Mutual of America Capital Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-62,342	Closed	-$2.41M	–	1446
2024 Q3	$2.41M	Sell	62,342 -13,586	-18%	-$485K	0.03%	816
2024 Q2	$2.44M	Sell	75,928 -16,874	-18%	-$585K	0.03%	790
2024 Q1	$3.6M	Sell	92,802 -7,173	-7%	-$251K	0.04%	642
2023 Q4	$3.08M	Sell	99,975 -21,389	-18%	-$536K	0.04%	700
2023 Q3	$2.71M	Sell	121,364 -7,535	-6%	-$172K	0.03%	712
2023 Q2	$2.77M	Sell	128,899 -9,493	-7%	-$216K	0.03%	773
2023 Q1	$3.32M	Sell	138,392 -6,184	-4%	-$164K	0.04%	697
2022 Q4	$3.35M	Buy	144,576 +2,094	+1%	+$42.2K	0.04%	666
2022 Q3	$2.28M	Buy	142,482 +136,776	+2,397%	+$2.41M	0.03%	789
2022 Q2	$101K	Buy	5,706 +725	+15%	+$12.2K	﹤0.01%	1497
2022 Q1	$101K	Buy	4,981 +258	+5%	+$4.87K	﹤0.01%	1515
2021 Q4	$88K	Sell	4,723 -20	-0.4%	-$390	﹤0.01%	1556
2021 Q3	$94K	Sell	4,743 -268	-5%	-$5.79K	﹤0.01%	1545
2021 Q2	$118K	Buy	5,011 +369	+8%	+$8.52K	﹤0.01%	1528
2021 Q1	$110K	Buy	+4,642	New	+$110K	﹤0.01%	1522

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Mutual of America Capital Management's COLL Position: Q4 2024 in Review

Mutual of America Capital Management sold out of Collegium Pharmaceutical (COLL) in Q4 2024, closing a stake of 62,342 shares — an estimated $2.41M sold.

Mutual of America Capital Management first reported a position in COLL in Q1 2021 and held it in 15 quarters. The position peaked at $3.6M in Q1 2024. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

Mutual of America Capital Management reported no remaining Collegium Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Mutual of America Capital Management sold 62,342 Collegium Pharmaceutical shares in Q4 2024, an estimated $2.41M.
Mutual of America Capital Management first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 15 quarters.
Mutual of America Capital Management's Collegium Pharmaceutical position peaked at $3.6M in Q1 2024.
238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Mutual of America Capital Management's 13F filing for Q4 2024, filed 5 Feb 2025.